Neoplasia/BPH

	Exploring key genes and prognostic validation of prostate cancer through transcriptome-wide association study. Sci Rep Li J, Tao T, Zhang Y, Kong X, Zhang Y, Chen S, Huang Y. PMID: 42401728 [PubMed - as supplied by publisher]
	Toward Interpretable Machine Learning Models for Grading Prostate Cancer: A Multicenter Development and Validation Study. Clin Genitourin Cancer Dai S, Lu D, Zheng W, Lv J, Huang B, Mu R, Huang D, Li P, Feng Y, Yang P, Li X, Zhu X, Qin X. PMID: 42401511 [PubMed - as supplied by publisher]
	Precise diagnosis of hepatocellular carcinoma and acute kidney injury through near-infrared imaging utilizing a fluorescence probe for monitoring Î±-l-fucosidase. Anal Chim Acta Mao CP, Tan JT, Wang K, Cai FF, Dai HB. PMID: 42401471 [PubMed - indexed for MEDLINE]
	Relationships of serum cabozantinib concentration with tumor response and adverse events in treatment of advanced renal cell carcinoma: observational exploratory prospective study. Int J Clin Oncol Doke Y, Noda S, Kusaba T, Yoshida T, Hira D, Ikeda Y, Kageyama S, Terada T, Morita SY. PMID: 42400775 [PubMed - as supplied by publisher]
	Artificial intelligence-enabled MRI surveillance of prostate cancer: integrating PRECISE v2, PI-QUAL, and longitudinal biomarkers-a narrative review. Abdom Radiol (NY) Fujiwara M, Pakpoor J, Aslan S, Tasdemir MN, Roest C, Arita Y, Purysko A, Giganti F. PMID: 42400610 [PubMed - as supplied by publisher]
	A Solid-State Near-Infrared Fluorescent Probe by a Synergistic Extended Conjugated System for Detecting Cys with Long-Term Imaging in Orthotopic Bladder Cancer. Anal Chem Wang ZQ, Song Q, Liu JY, Peng CY, Li XH, Mao GJ, Hu L, Ouyang J, Li CY. PMID: 42400487 [PubMed - as supplied by publisher]
	Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC). BJU Int Pasanen N, Talala K, Remmers S, Tammela TLJ, Hugosson J, Godtman RA, Taari K, Bangma C, Hond ED, Nelen V, Wyler S, Kwiatkowski M, Puliti D, Gorini G, Gonzàlez L, Lujan M, Roobol MJ, Auvinen A. PMID: 42400346 [PubMed - as supplied by publisher]
	Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics. Eur Urol Fanti S, Turco F, Tombal B, Walz J, Hofman MS, Hadaschik B, Emmett L, Tilki D, Pecoraro G, Salfi G, Attard G, Beltran H, Bjartell A, Briganti A, Burger IA, Castro E, Cerci JJ, Chiti A, Cooperberg M, Fizazi K, Fossati N, Gafita A, Gallina A, Goffin K, Horvath LG, Hugosson J, Iagaru A, James ND, Kasivisvanathan V, Koh DM, Kristiansen G, Kumar R, Lecouvet F, Loeb S, McKay RR, Morris MJ, Murphy DG, Murthy V, Naoun N, Oprea-Lager DE, Ost P, O'Sullivan J, Padhani AR, Palapattu G, Paone G, Petralia G, Roobol MJ, Sartor OA, Sathekge M, Schuster DM, Seibert TM, Spratt DE, Tempany C, Tunariu N, Vargas HA, Vogl UM, Wyatt AW, Zilli T, Lin HM, Omlin A, Gillessen S, Herrmann K. PMID: 42399196 [PubMed - as supplied by publisher]
	How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice consensus recommendations. Radiother Oncol Willigenburg T, Draulans C, Pos FJ, Seibert TM, Syndikus I, Henry A, Mitchell A, Buijs M, Jereczek-Fossa BA, Spohn SKB, Pommer T, Pieters BR, Tree AC, van der Voort van Zyp JRN. PMID: 42399065 [PubMed - indexed for MEDLINE]
	Integrative Traditional East Asian Medicine-Based Adjunctive Therapies for Patients With Prostate Cancer Undergoing Standard Cancer Treatment: Protocol for a Systematic Review and Meta-Analysis of Randomized Controlled Trials. JMIR Res Protoc Wi SJ, Kim DH, Kim SH, Lee SJ, Park JS, Shin SM, Lee BC, Park SJ. PMID: 42398929 [PubMed - indexed for MEDLINE]
	Nanomedicine-based sensitization and resistance reversal in immunotherapy of clear cell renal cell carcinoma: from tumor microenvironment to precision delivery. Med Oncol Ma J, Qiang Z, Xie W, Jiao L, Mi L, Ma K, Yang Z, Chen G. PMID: 42397660 [PubMed - indexed for MEDLINE]
	Holmium laser enucleation of the prostate as salvage therapy for benign prostatic obstruction after multiple prior surgical interventions. World J Urol Bakbak H, Singh G, Abdelaziz A, Bhatia A, Velasquez Ospina J, Sharma ND, Fuentes AJ, Katz JE, Shah HN. PMID: 42397584 [PubMed - indexed for MEDLINE]
	Evolving role of biomarkers beyond prostateâ€‘specific antigen in refining prostate cancer screening: From bloodâ€‘based tests to urinary and genetic markers (Review). Mol Med Rep Li L, Zhang L, Li Z, Chai K, Ren W. PMID: 42396659 [PubMed - indexed for MEDLINE]
	Case Report: Kidney preservation using immune checkpoint inhibitors in Muir-TorrÃ© syndrome-associated upper tract urothelial carcinoma, with literature review. Front Immunol Hanna M, Bar-Sela G. PMID: 42396450 [PubMed - indexed for MEDLINE]
	Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer. Endocr Oncol Gorman M, Usmani N, Pollak MN, Ghosh S, Elangovan A, Kim J, Thoms J, Bouchard M, Peacock M, Wang Y, Fleshner NE, Campbell H, Vigneault E, Vincent F, So A, Cury FL, Quon HC, Carlson RG Jr, Lambert C, Klotz L, Chi K, Brundage M, Courneya KS, Eigl BJ. PMID: 42395839 [PubMed]
	A Visually Interpretable Histopathology-Based Immune Model Predicts T-effector Biology and Response to Immune checkpoint inhibition in Clear Cell Renal Cell Carcinoma Clinical Trial and Contemporary Real-World Datasets. bioRxiv Perny A, Jarmale V, Jasti J, Zhong H, Christie A, Miyata J, Nielson A, Kontoyiannis P, Rakheja D, Modrusan Z, Huseni M, Kadel W, Brugarolas J, Kapur P, Rajaram S. PMID: 42395467 [PubMed]
	Optimization of Administered Activity for (64) Cu-SAR-bisPSMA PET Imaging in Primary Prostate Cancer: Results from a Phase I Retrospective Study (PROPELLER Sub-study). World J Nucl Med Lengyelova E, Patel M, Morrish G, Mittra E, Malaroda A, Gervasio O, Armor T. PMID: 42395167 [PubMed]
	LLMs in Problem-Based Learning: The Grounding Issue. Stud Health Technol Inform Sariyar M. PMID: 42394097 [PubMed - indexed for MEDLINE]
	Estimating Mosaic Loss of the Y Chromosome in Male Bladder Cancer Participants Using "All of Us" Data. Stud Health Technol Inform Ye Z, Cui W, Theodorescu D, Finkelstein J. PMID: 42394043 [PubMed - indexed for MEDLINE]
	When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [Â¹â¸F]FDG in high-risk prostate cancer: dual-tracer cohort study. Cancer Imaging Ibrahim EA, Alper E. PMID: 42393801 [PubMed - as supplied by publisher]

Articles 1 - 20 / 189450

Page 1 of 9473



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy